Mark Bellringer

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Cancer is a group of diseases driven by inherently nanostructural problems (e.g. DNA issues). As such, there are obvious benefits to treatments employing nanoscale structures and processes. Additionally, as nanotechnologies are developing at a rapid rate, it is likely that many new themes will develop within the area in the next few years. With this in(More)
  • 1